Edit
Clee Medical
https://wysscenter.ch/advances/epios-brain-monitoringLast activity: 03.03.2025
Active
Long-term brain monitoring and therapeutics for personalized management of neuro-disorders
Location: Switzerland, Geneva
Employees: 11-50
Founded date: 2015
Investors 2
| Date | Name | Website |
| 05.08.2024 | Venture Ki... | venturekic... |
| 19.05.2021 | MassChalle... | masschalle... |
Mentions in press and media 16
| Date | Title | Description |
| 03.03.2025 | EPFL spin-off sets record for brain interface space for epilepsy monitoring | Based at Campus Biotech in Geneva, Neurosoft has developed a novel brain interface designed to detect key epilepsy biomarkers - high-frequency oscillations and fast ripples - allowing surgeons to identify epileptic tissue with unprecedente... |
| 12.02.2025 | Successful human trials and milestones for BrainScape Medical | BrainScape Medical, a newly incorporated company pioneering long-term brain monitoring and neurostimulation technology, has just announced several significant milestones in its journey. BrainScape Medical, formed in Q4 2024, has completed ... |
| 14.12.2024 | dEEGtal Insight: A New Dawn for Epilepsy Diagnosis | Epilepsy is a silent storm. Each year, around 10 million people face their first seizure. Yet, up to 80% of initial EEG readings come back normal. This reality is a bitter pill for patients. Delayed diagnoses can lead to a 70% risk of relap... |
| 13.12.2024 | dEEGtal Insight secures CHF 1M to revolutionize epilepsy diagnosis | Each year, around 10 million people worldwide experience a possible first epileptic seizure, but up to 80% of initial EEG readings appear normal. This delays diagnoses and increases the risk of relapse to 70% in untreated patients, signific... |
| 11.06.2024 | Dandelion Science and the Wyss Center Geneva announce AI partnership to generate non-invasive brain therapies | GENEVA, June 11, 2024 /PRNewswire/ -- The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science are excited to announce a partnership focused on a cutting-edge generative AI neuromodulation platform that could speed the d... |
| 28.02.2024 | Fresh funding to drive Artiria Medical forward | Founded in 2019, Artiria Medical is on a mission to revolutionize minimally invasive surgical interventions for the better treatment of stroke patients. Its leading product is a novel real-time deflectable guidewire that enables neurointer... |
| 14.12.2023 | IMD reveals the 29 winners of the 2024 Startup Challenge | |
| 04.04.2023 | CHF 120 million and a new CEO to accelerate therapies for brain disorders | |
| 28.02.2022 | GliaPharm braces to enter the clinical phase | |
| 28.10.2021 | MassChallenge Switzerland Awards Equity-Free Cash Prizes to Top 2021 Startups | Lausanne, Switzerland – MassChallenge Switzerland, part of MassChallenge’s global network for innovators and zero-equity startup accelerators, tonight awarded CHF 500,000 in equity-free cash prizes and in-kind awards to the top 12 startups ... |
Show more